Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India
Global deep brain stimulator market sales were valued at around US$ 1.18 Bn at the end of 2021. The market is projected to register a 10.4% CAGR and top a valuation of US$ 3.47 Bn by 2032.
“Rapidly increasing geriatric population, high prevalence of neurological disease and availability of advanced deep brain stimulation technology will help the global deep brain stimulator market to generate great revenue in the forecasted period.”
Surgery that involves the implantation of an electrical device within the body is known as deep brain stimulation. This device transmits electrical signals to the part of the brain that controls the movement of the body. Additionally, deep brain stimulation device refers to the equipment used to monitor brain stimulation. Deep Brain Stimulation (DMS) is a treatment option for several immobilizing neurological conditions. It includes implanting a neurostimulator, a battery-powered medical device that transmits electrical signals to particular regions of the brain that regulate movement and affective issues like mood, pain, awakening and weight. A common neurological movement problem called essential tremor can also be treated with this treatment. The DMS system consists of three parts: the neurostimulator, which generates the electric current and is typically positioned under the skin near the collarbone, the extension, which connects the lead to the neurostimulator, and a thin, insulated wire called the electrode or lead that is inserted into the brain.
Attributes |
Details |
Deep Brain Stimulator Market Value in 2021 |
US$ 1.18 Bn |
Deep Brain Stimulator Market Value in 2032 |
US$ 3.47 Bn |
Deep Brain Stimulator Market CAGR (2022-2032) |
10.4% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The key factor fuelling the market for deep brain stimulation devices is the rising prevalence of dystonia and Parkinson's disease. Deep brain stimulation is adjustable and can be modified as the patient's disease or response to treatment changes. Additionally, this electrical injection is less complicated than pallidotomy and thalamotomy because it does not involve damage to any region of the brain. Another significant market driver is the rising demand for minimally invasive procedures as a result of better patient outcomes.
Furthermore, this industry is expected to experience growth due to technological developments in DBS technologies. Improved microelectrode designs, robotic implantation, rechargeable implantable pulse generators, multi-target stimulation, and customized directed programming are some of these technological advancements which propel the market for deep brain stimulator market in the forecasted period.
In the deep brain stimulator market, the North American region holds the highest market share followed by the Asian region. The demand for deep brain stimulators is anticipated to rise as a result of campaigns to improve awareness of Parkinson's disease (PD) and increased government funding will boost the market growth in the North American region. Furthermore, the existence of significant competitors and the availability of sophisticated healthcare infrastructure all contribute to the expansion of this market.
Latin America, the Middle East, and Africa regions are at a blossoming stage and are expected to show sustainable growth shortly, owing to the prevalence of various neurological disorders.
Some of the key players operating in the deep brain stimulator market are St. Jude Medical, Neuropace Inc., Boston Scientific Corporation, LivaNova PLC, Medtronic, Aleva Neurotherapeutics S.A., Nexstim, Medtronic, Beijing PINS Medical Co. Ltd, SceneRay Co., Ltd., SceneRay Co. among others.
Report Attributes |
Details |
Growth Rate |
CAGR of 10.4% 2022-2032 |
Base Year for Estimation |
2021 |
Historical Data |
2012-2021 |
Forecast Period |
2022-2032 |
Qualitative Units |
Revenue in USD Billion, Volume in Units and CAGR from 2022-2032 |
Report Coverage |
Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
Segment Covered |
|
Region Covered |
|
Key Countries Profiled |
|
Key Players |
|
Customization |
Available Upon Request |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The global deep brain stimulator market is anticipated to register a CAGR of 10.4% during the forecast period.
The top 3 players in the global deep brain stimulator market are St. Jude Medical, Boston Scientific Corporation and SceneRay Co.
Recommendations
Explore Healthcare Insights
View Reports